Your Location：
Home >
Browse articles >
Licochalcone A in Inhibiting Bleomycin-induced Pulmonary Fibrosis Through TGF-β/Smad Pathway
Licochalcone A in Inhibiting Bleomycin-induced Pulmonary Fibrosis Through TGF-β/Smad Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 4, Pages: 94-100(2019)
DOI： 10.13422/j.cnki.syfjx.20190402
Scan QR Code
Full Text(HTML)
Figs( 4 ) Tabs( 5 )
References
Publication Info
Metrics
62
Views
55
Downloads
6
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Jinshui Huanxian Component Formula Ⅱ Combined with Matrix Softening in Ameliorating Pulmonary Fibrosis Through Inhibition of Epithelial-mesenchymal Transition
Sanjie Quban Prescription Affects Proliferation， Apoptosis， Migration， and Invasion of Human Keloid Fibroblasts via AhR/CYP1A1 Signaling Pathway
Role of Fluid Shear Stress in Pulmonary Fibrosis from Perspective of Lung Linking with All Vessels
Effect and Mechanisms of Bushen Tongluo Prescription on Pulmonary Fibrosis via Inhibiting Macrophage Polarization Through Wnt3a/β-catenin Signaling Pathway
A Systematic Strategy for Discovering First-in-class Anti-fibrotic Drugs from Traditional Chinese Medicine
Related Author
WU Xiaojie
LI Mingyan
KUANG Shiyu
PENG Xiling
HOU Xiaorong
LIU Han
HE Zhihong
ZHANG Fengchuan
Related Institution
Henan Key Laboratory of Chinese Medicine for Respiratory Disease， Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Ministry of Education of China， Academy of Chinese Medical Sciences， Henan University of Chinese Medicine
Dongfang Hospital of Beijing University of Chinese Medicine
National Center for Integrated Traditional Chinese and Western Medicine， China-Japan Friendship Hospital
Beijing University of Chinese Medicine
Academy of Chinese Medical Sciences， Hunan University of Chinese Medicine
Chat
